Alex Ng
Chief Scientific Officer & Co-Founder GC Therapeutics
Seminars
Wednesday 1st October 2025
Rewriting the Rules of Differentiation: Driving iPSC Fate Through Direct Nuclear Reprogramming with TFome
4:30 pm
- Leveraging transcription factors (TFs) to drive differentiation without relying on cellexternal cues
- Achieving up to 99% efficiency in four days through a single-step, cost-effective approach
- Integrating AI and high-throughout experimentation to discover key TFs for scalable, precision-driven differentiation
Wednesday 1st October 2025
Industry Leaders Fireside Chat: Understanding the Investment Landscape & Novel Opportunities in the iPSC Space
9:00 am
An interactive panel discussion from the industry leaders of the field to set the scene on the iPSC therapy space. Ask your questions live to understand the expert’s thoughts on key topics including:
- Key factors influencing investment in iPSCs, including tech advancements, novel data and regulatory changes
- Addressing risks in iPSC development and strategies for attracting investment
- Novel iPSC-based therapy areas, such as tissue regeneration and biotech-academic collaborations advancing the field
